Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market
The multidrug-resistant bacterium methicillin-resistant Staphylococcus aureus (MRSA) is the most common kind of staphylococcus aureus. In August of this year, the CDC reported that almost one in fifty Americans had MRSA in their noses. These people are also four times more likely to become ill after being exposed to an infectious agent. The superbug MRSA is endemic to healthcare settings and can lead to life-threatening complications like bloodstream infections, pneumonia, sepsis, and even death. Kits, reagents, tools, and software are all available for diagnosing an MRSA infection. The novel DNA-based tests are quick, but their high price makes widespread adoption unrealistic. Culture techniques, used in conventional approaches, take days to confirm a positive result and 48 hours to rule out MRSA. Yet, technologies enable hospitals to use screening to improve patient outcomes and reduce cross-contamination hazards at a reasonable cost.
By the end of the forecast period in 2020, the worldwide market for Testing System of MRSA is projected to have reached a value of US$ 105.08 Mn (2020-2027) with a CAGR of 10.5%.
Get Sample Copy Here : https://www.coherentmarketinsights.com/insight/request-sample/3803
Growth of the market for testing system of MRSA is anticipated to be driven by factors such as the rising incidence of MRSA infections and the approval of products produced by industry competitors.
The market for MRSA testing systems is anticipated to expand on account of the rising incidence of MRSA infections around the world. Almost 120,000 staphylococcus aureus bloodstream infections and 20,000 deaths were reported in the United States in 2017, according to a report from the Department of Health and Human Services published in March 2019. While MRSA infections have been steadily declining over the past few years, methicillin-susceptible S. aureus infections in hospitals continue to rise steadily in the general population.
In addition, product consents by regulatory authorities are anticipated to boost the MRSA Testing Systems market in the coming years. For example, Luminex Corporation reported in October 2019 that it has gained 510(k) clearance from the FDA for the ARIES MRSA Assay. MRSA DNA can be directly detected from nasal swabs in high-risk people using this qualitative in vitro diagnostic technique. It is an combined, real-time, polymerase chain reaction (PCR) based test. The Luminex ARIES System is a real-time device built to boost lab productivity, guarantee reliable results, and easily integrate into today’s advanced research facilities.
Market for testing system of MRSA– Restraints
Development of the market for methicillin-resistant staphylococcus aureus testing systems may be limited, however, by rising product recalls of MRSA testing systems. For example, in August of this year, the United States Food and Drug Administration (FDA) issued a recall for the BD Max MRSA test kit manufactured by Becton Dickinson & Company due to potential leakage from improperly wrapped foil packages holding extraction tubes for BD MAX Reagent products. In order to raise awareness and forestall erroneous test findings, an alert was sent to all users of BD Max devices at testing facilities.
Avail Discount UPTO 25% Limited Time Offer : https://www.coherentmarketinsights.com/insight/request-discount/3803
Market for testing system of MRSA– Regional Analysis
Mergers and acquisitions in the United States have led to North America becoming the largest market for methicillin-resistant staphylococcus aureus (MRSA) testing systems in 2019. In April of 2017, for example, Avantor Performance Materials, LLC, declared cGMP buffers and solutions for Biopharma customers and high-purity chemistries for Research and Electronic Materials customers are now available through the company’s acquisition of Puritan Products, Inc. By acquiring the Puritan Products brand, Avantor was able to increase its cGMP operations, strengthen its supply chain, and hire experts in the production of high-purity materials like those at Puritan MRSA Transport Medium, Macron Fine Chemicals, J.T.Baker, and Puritan brands of high-purity products and packaging.
Also, industry leaders are concentrating on product consents to secure rights for commercial purpose for product sales in a specific country. The market for MRSA testing systems in Europe is anticipated to expand in response to this trend. An example is the cobas MRSA/SA Test, which was released by Roche as a CE-IVD in January 2014 for the rapid, simultaneous identification of methicillin-resistant and methicillin-sensitive staphylococcus aureus (MRSA and SA, respectively) in nasal swabs. For successful MRSA/SA infection prevention and control, the cobas MRSA/SA test’s single-sample detection is invaluable. The cobas MRSA/SA test uses the most cutting-edge real-time polymerase chain reaction (PCR) intensification and uncovering methods, as well as automation on the cobas 4800 System, to process specimens in a short amount of time.
Market for testing system of MRSA- Competitive Landscape
MRSA testing systems are dominated by the following companies: F.Hoffmann-La Roche, Becton, Dickinson and Company, Hain Lifescience GmbH, BioMérieux, 3M Company, Bio-Rad Laboratories Inc., Abacus Diagnostica, Abbott Laboratories, Puritan Medical Products, Diatherix Eurofins, LLC, Arlington Scientific Inc., AdvanDx, Genspeed Biotech GmbH, Cepheid Inc., Luminex Corporation, and R-Biopharm AG.
| The market size value in 2023 |
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Market Overview
- Definition of Assistive Technology Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Assistive Technology Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Buy Now : https://www.coherentmarketinsights.com/insight/buy-now/3803
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Explore More Related Insights:
Electronic health record ehr systems market analysis
Us corporate wellness market analysis
Green hospitals market analysis
Clinical workflow solutions market analysis
Crispr genomic cure market analysis
Personal emergency response systems market analysis
Healthcare it consulting market analysis
Real world data rwd market analysis
Digital therapeutics market analysis
Healthcare fabrics market analysis
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837